By Cesar Pinto
Covidien, a leading global provider of healthcare products, has announced that it’s tissue reinforcement product, Duet TRS, has been connected with the deaths of three patients who underwent chest surgery. Thirteen other patients have sustained serious personal injuries. For these reasons, Covidien has issued a voluntary recall of all tissue reinforcers in the Duet TRS product line. Philadelphia personal injury attorneys of Messa & Associates urge patients who may affected by this recall to contact their physicians immediately.
The manufacturer of the defective medical device admitted that the Duet TRS has the potential to injure adjacent anatomical structures within the thorax, which may result in life-threatening, post-operative complications.
The tissue reinforcement product is applied to a patient at the same time as medical staples during chest surgeries, but should no longer be used during those surgeries due to the risks of serious injury and death. Covidien reported that they have sold 500,000 of the devices since 2009.
The Philadelphia personal injury attorneys at Messa & Associates are experienced in handling cases involving pharmaceutical and medical device injuries. Our extremely skilled team of personal injury attorneys and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a defective medical device, a negligent medical provider, or have endured any other type of personal injury, contact the personal injury attorneys of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.